It is a pharma private limited company based in Aurangabad, Maharashtra, India, established in 2022.
2022 | Aurangabad, Maharashtra, India | ActiveEdrok Formulation Private Limited, a active private limited company, was established on 06 May 2022 in Aurangabad, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2022PTC382099. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.10 M and a paid-up capital of ₹4.10 M.
Its leadership includes Rahul Bhaurao Korade (Director), Vijeta Rahul Korade (Director). Past directors included Swapnil Raosaheb Shelke. It holds ₹4.89 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. A-14 Midc Waluj, Aurangabad, Maharashtra, 431001.
U24230MH2022PTC382099
382099
06 May 2022
₹4.10 M
₹4.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Edrok Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Bhaurao Korade | Director | 06 May 2022 | Current |
| Vijeta Rahul Korade | Director | 10 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Edrok Formulation's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Edrok Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹48,892,918.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2024 | Others | ₹2.90 Cr | Open |
| 24 Nov 2022 | Others | ₹1.99 Cr | Open |
Explore comprehensive loan charge details -
Edrok Formulation has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Edrok Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edrok Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 28.99 M with Charge ID 101028065 was registered on 16 Nov 2024. was completed.
Progress on Edrok Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Vijeta Rahul Korade was appointed as a Director was appointed as a Director on 10 Aug 2024 & has been associated with this company since 1 year 4 months . was documented.
The activity Edrok Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge with Others amounted to Rs. 19.90 M with Charge ID 100647974 was registered on 24 Nov 2022. was completed.
Rahul Bhaurao Korade was appointed as a Director was appointed as a Director on 06 May 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
The CIN of Edrok Formulation Private Limited is U24230MH2022PTC382099.
Edrok Formulation Private Limited is headquartered at Plot No. A-14 Midc Waluj, Aurangabad, Maharashtra, 431001.
Edrok Formulation Private Limited was incorporated on 06 May 2022.
The current directors of Edrok Formulation Private Limited are
The primary industry of Edrok Formulation Private Limited is Pharma.
Edrok Formulation Private Limited is unlisted.
The authorized capital of Edrok Formulation Private Limited is ₹4.10 M, and the paid-up capital is ₹4.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX